CD274 and neoplasm: Under conditions of active anti-tumor immunity, DDR scores have been found to positively correlate with immune-related biomarkers, such as the number of T cells (such as CD4+ activated memory cells, CD8+ cells), T-cell receptor repertoire, PDL1 expression, and broad immune infiltrate.